To investigate the molecular mechanism underlying the in vivo effects of APC haploinsufficiency-enhanced GBM progression, we examined cell death (TUNEL assay) and cell proliferative (Ki-67 and Phospho-Histone 3 markers) activities using immunohistochemistry (Figure 3Ai,Aii). The gene discussed is MKI67; the disease is glioblastoma.